Thema
Adalimumab
11.444
FYS6T7F842
7.203
Journal Article
6.788
Infliximab
4.583
Antibodies, Monoclonal, Humanized
3.584
Tumor Necrosis Factor-alpha
3.295
Etanercept
3.088
B72HH48FLU
3.043
Antibodies, Monoclonal
2.872
Antirheumatic Agents
2.315
OP401G7OJC
1.917
Research Support, Non-U.S. Gov't
1.910
Case Reports
1.695
Anti-Inflammatory Agents
1.671
adalimumab
1.319
Review
1.270
Immunoglobulin G
1.176
Receptors, Tumor Necrosis Factor
1.130
Methotrexate
1.124
Letter
929
YL5FZ2Y5U1
735
Multicenter Study
685
Biological Products
680
Psoriasis
617
Comparative Study
599
Immunosuppressive Agents
598
Rheumatoid Arthritis
596
Randomized Controlled Trial
545
Tumor Necrosis Factor Inhibitors
523
Ustekinumab
521
infliximab
497
Crohn’s disease
460
FU77B4U5Z0
436
Rheumatoid arthritis
434
Observational Study
425
Gastrointestinal Agents
393
golimumab
392
Dermatologic Agents
364
Certolizumab Pegol
353
Biosimilar Pharmaceuticals
331
psoriasis
317
UMD07X179E
310
91X1KLU43E
307
Systematic Review
300
Comment
292
Anti-Inflammatory Agents, Non-Steroidal
271
Biomarkers
267
Immunologic Factors
267
rheumatoid arthritis
257
Psoriatic Arthritis
246
mehr ...